Peptide Therapy: Complete Guide

What Is Peptide Therapy?

Peptide therapy is the therapeutic use of peptides — short chains of amino acids — to treat medical conditions or optimize health. It encompasses both FDA-approved peptide drugs (like insulin, semaglutide, and tesamorelin) prescribed through conventional medicine and off-label use of research peptides in integrative medicine clinics.

The field has grown dramatically since 2020, driven by the success of GLP-1 agonists for weight loss and increasing interest in regenerative medicine. Over 80 peptide drugs are FDA-approved, with hundreds more in clinical trials.

Administration Methods

Subcutaneous injection: The most common route for therapeutic peptides. A small needle injects the peptide into the fatty tissue just under the skin (usually abdomen, thigh, or upper arm). Most GLP-1 agonists come in pre-filled pens that make self-injection straightforward. Research peptides typically require reconstitution from lyophilized powder and drawing from a vial with an insulin syringe.

Oral administration: Available for some peptides — oral semaglutide (Rybelsus), collagen peptides, and BPC-157 capsules. Most peptides are broken down by digestive enzymes, so oral delivery requires special formulation (like the SNAC enhancer in Rybelsus) or relies on local gut effects (BPC-157).

Intranasal: Peptides like Semax, Selank, and some BPC-157 formulations are administered as nasal sprays. This provides relatively rapid absorption and, for neuropeptides, may allow more direct access to the brain.

Topical: Cosmetic peptides (GHK-Cu, matrixyl, argireline) are applied to the skin in serums and creams. Systemic absorption is minimal, making this the safest route but limited to local effects.

Intravenous (IV): Some clinical settings use IV peptide infusions (e.g., cerebrolysin for neurological conditions). This is not self-administered and requires medical supervision.

Finding a Qualified Provider

For FDA-approved peptides, any licensed physician can prescribe them. For off-label peptide therapy, look for providers with specific peptide training:

Board certification: Physicians board-certified in functional medicine, integrative medicine, anti-aging medicine (A4M), or endocrinology are most likely to have peptide expertise.

Specialized training: Organizations like the International Peptide Society and A4M offer peptide therapy certification. Ask providers about their specific training in peptide protocols.

Red flags to avoid: Providers who prescribe without proper evaluation, sell peptides directly at large markups without transparency, promise guaranteed results, or discourage lab monitoring. Quality providers will order baseline labs, monitor progress, and adjust protocols based on individual response.

Telehealth peptide clinics: The rise of telehealth has made peptide therapy more accessible. Many clinics now offer virtual consultations with licensed providers. Verify that the prescribing physician is licensed in your state and that prescriptions go through a licensed pharmacy.

Cost of Peptide Therapy

FDA-approved peptides: Insurance often covers these when prescribed for approved indications. Out-of-pocket costs range from $0-1,350/month depending on insurance and specific medication. Manufacturer savings programs can significantly reduce costs.

Compounded peptides: Typically $100-500/month depending on the peptide and compounding pharmacy. Not covered by insurance. Quality compounding pharmacies (PCAB-accredited) tend to be more expensive but more reliable.

Clinic/provider fees: Initial consultations typically $200-500, follow-ups $100-300. Some clinics bundle peptides and consultations into monthly programs ($300-1,500/month).

Lab monitoring: Baseline and follow-up labs (hormones, metabolic panels, etc.) typically $200-600 per round, sometimes covered by insurance if ordered under a medical diagnosis.

Regulatory Landscape (2026)

The peptide regulatory environment has been evolving rapidly:

FDA-approved peptides are fully regulated, manufactured under GMP standards, and available through licensed pharmacies. These include semaglutide, tirzepatide, tesamorelin, insulin, and dozens of others.

503A compounding pharmacies can compound peptides for individual patients with a valid prescription when a commercially available product does not meet the patient's needs (e.g., different dosage form or during drug shortages). The FDA has been increasing scrutiny of compounded GLP-1 agonists as shortages resolve.

503B outsourcing facilities can produce compounded drugs in larger batches without individual prescriptions but must register with the FDA and comply with current good manufacturing practices.

Research peptides sold "for research purposes only" occupy a legal gray area. They cannot be marketed for human consumption but are widely available online. Quality control varies dramatically between vendors.

What to Expect from Peptide Therapy

Timeline: Effects vary by peptide. GLP-1 agonists may reduce appetite within days. GH secretagogues typically show sleep improvement in 1-2 weeks, body composition changes in 3-6 months. Healing peptides may show progress in 2-8 weeks. Cosmetic peptides need 8-12 weeks of consistent use.

Monitoring: Quality providers will order labs before starting therapy and at regular intervals (usually every 3-6 months). Key markers depend on the peptide but may include: metabolic panel, lipid panel, HbA1c, IGF-1, testosterone/estrogen, thyroid function, and inflammatory markers.

Cycling: Some peptides are used continuously (GLP-1 agonists for weight management), while others are cycled (GH secretagogues are often used 5 days on / 2 days off, or for 3-6 month courses). Your provider should advise on the appropriate protocol for your specific situation.

Browse Peptides by Goal